169 related articles for article (PubMed ID: 20570056)
21. Suppression of hepatitis B virus replication in Tupaia hepatocytes by tumor necrosis factor alpha of Tupaia belangeri.
Xu Y; Köck J; Lu Y; Yang D; Lu M; Zhao X
Comp Immunol Microbiol Infect Dis; 2011 Jul; 34(4):361-8. PubMed ID: 21684599
[TBL] [Abstract][Full Text] [Related]
22. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
Jaoudé GA; Sureau C
J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
[TBL] [Abstract][Full Text] [Related]
24. Asialoglycoprotein receptor interacts with the preS1 domain of hepatitis B virus in vivo and in vitro.
Zhang X; Lin SM; Chen TY; Liu M; Ye F; Chen YR; Shi L; He YL; Wu LX; Zheng SQ; Zhao YR; Zhang SL
Arch Virol; 2011 Apr; 156(4):637-45. PubMed ID: 21207081
[TBL] [Abstract][Full Text] [Related]
25. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange.
Abou-Jaoudé G; Sureau C
J Virol; 2007 Dec; 81(23):13057-66. PubMed ID: 17898062
[TBL] [Abstract][Full Text] [Related]
26. microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture.
Xu G; Gao Z; He W; Ma Y; Feng X; Cai T; Lu F; Liu L; Li W
Virology; 2014 Jan; 448():247-54. PubMed ID: 24314655
[TBL] [Abstract][Full Text] [Related]
27. Property of hepatitis B virus replication in Tupaia belangeri hepatocytes.
Sanada T; Tsukiyama-Kohara K; Yamamoto N; Ezzikouri S; Benjelloun S; Murakami S; Tanaka Y; Tateno C; Kohara M
Biochem Biophys Res Commun; 2016 Jan; 469(2):229-35. PubMed ID: 26654952
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.
Deng Q; Zhai JW; Michel ML; Zhang J; Qin J; Kong YY; Zhang XX; Budkowska A; Tiollais P; Wang Y; Xie YH
J Virol; 2007 Apr; 81(8):4244-54. PubMed ID: 17192308
[TBL] [Abstract][Full Text] [Related]
29. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
[TBL] [Abstract][Full Text] [Related]
30. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.
Sprinzl MF; Oberwinkler H; Schaller H; Protzer U
J Virol; 2001 Jun; 75(11):5108-18. PubMed ID: 11333892
[TBL] [Abstract][Full Text] [Related]
31. Live Cell Imaging Confocal Microscopy Analysis of HBV Myr-PreS1 Peptide Binding and Uptake in NTCP-GFP Expressing HepG2 Cells.
König A; Glebe D
Methods Mol Biol; 2017; 1540():27-36. PubMed ID: 27975305
[TBL] [Abstract][Full Text] [Related]
32. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
[TBL] [Abstract][Full Text] [Related]
33. [Study on the relations between hepatitis B virus large surface protein (LHBs) and HBV YMDD mutation].
Wang LJ; Sun Y; Fu HP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):48-9. PubMed ID: 20848850
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of hepatitis B virus attachment and entry.
Lempp FA; Urban S
Intervirology; 2014; 57(3-4):151-7. PubMed ID: 25034482
[TBL] [Abstract][Full Text] [Related]
35. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.
Hantz O; Parent R; Durantel D; Gripon P; Guguen-Guillouzo C; Zoulim F
J Gen Virol; 2009 Jan; 90(Pt 1):127-35. PubMed ID: 19088281
[TBL] [Abstract][Full Text] [Related]
36. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
[TBL] [Abstract][Full Text] [Related]
37. Efficient inhibition of hepatitis B virus replication by small interfering RNAs targeted to the viral X gene in mice.
Shin D; Kim SI; Kim M; Park M
Virus Res; 2006 Aug; 119(2):146-53. PubMed ID: 16443303
[TBL] [Abstract][Full Text] [Related]
38. Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.
Lucifora J; Esser K; Protzer U
Antiviral Res; 2013 Feb; 97(2):195-7. PubMed ID: 23266293
[TBL] [Abstract][Full Text] [Related]
39. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
40. Interaction of hepatitis B virus with cells.
Paran N; Cooper A; Shaul Y
Rev Med Virol; 2003; 13(3):137-43. PubMed ID: 12740829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
